Breast cancer incidence by estrogen receptor status in Denmark from 1996 to 2007

J Bigaard, C Stahlberg, M-B Jensen, M Ewertz, N Kroman

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Abstrakt

During the past 50 years, breast cancer incidence has increased by 2-3 % annually. Despite many years of testing for estrogen receptors (ER), evidence is scarce on breast cancer incidence by ER status. The aim of this paper was to investigate the increase in breast cancer incidence by ER status. Data were obtained from the clinical database of the Danish Breast Cancer Cooperative Group which holds nationwide data on diagnosis, including pathology, treatment, and follow-up on primary breast cancers since 1977. All Danish women
OriginalsprogEngelsk
TidsskriftBreast Cancer Research and Treatment
Vol/bind136
Udgave nummer2
Sider (fra-til)559-64
Antal sider6
ISSN0167-6806
DOI
StatusUdgivet - 2012

Fingeraftryk Dyk ned i forskningsemnerne om 'Breast cancer incidence by estrogen receptor status in Denmark from 1996 to 2007'. Sammen danner de et unikt fingeraftryk.

Citationsformater